10/14 · WedPicks
Latest picks
监管与产业动态精选评分6868 FDA Drugs精选评分6161 FDA approves first drug to improve functional capacity and symptoms in children with rare inherited heart condition
最新进展10月14日 12:53玛伐凯泰拟纳入中国优先审评
JAMA精选评分5454 Updated Stroke Guideline Emphasizes Early, Holistic Intervention
JAMA精选评分7171 FDA Approves 2 New Alzheimer Disease Blood Tests
FDA Drugs精选评分5555 Hanlim Pharm Co., Ltd. - 734782 - 10/02/2026
Nature Biotechnology精选评分8080 FDA nod for rare neurology drug
FDA Drugs精选评分7373 Hiding in Plain Sight: 7-OH Products
Nature Biotechnology精选评分8484 RevMed’s pancreatic cancer drug first
最新进展10月12日 22:20Rasonque获FDA早期批准，审评文件披露KRAS亚型ORR差异
中文产业新闻精选Chinese source评分7070 罗氏IL-6抗体Vamikibart基于两项III期52周数据递交葡萄膜炎黄斑水肿上市申请
中文产业新闻精选Chinese source评分7373 FDA批准梯瓦WELTRUZA，每月一次皮下注射长效奥氮平用于精神分裂症
FDA Drugs精选评分8787 FDA Approves Drug to Treat Lesions Caused by Herpes Simplex Virus
BioPharma Dive精选评分5454 HHS launches new plan to strengthen vaccine injury research, reporting
中文产业新闻精选Chinese source评分7777 北京佰仁医疗经导管肺动脉瓣膜系统获NMPA批准上市
STAT News精选评分7272 Trump administration investigates 9 universities for alleged visa fraud
FDA Drugs精选评分9393 FDA approves atezolizumab in combination with chemotherapy for Stage III mismatch repair deficient colon cancer
中文产业新闻精选Chinese source评分7474 金赛药业6个月制剂亮丙瑞林获NMPA批准上市，用于前列腺癌雄激素去势治疗
中文产业新闻精选Chinese source评分7575 三生制药紫杉醇口服溶液（柏瑞素）乳腺癌适应症获NMPA批准
中文产业新闻精选Chinese source评分7979 德达博妥单抗在华获批第二项乳腺癌适应症，覆盖不适合免疫治疗的mTNBC
监管与产业动态精选评分7474 MHRA approves catumaxomab to treat cancer-related fluid build-up in the abdomen
中文产业新闻精选Chinese source评分7979 诺华remibrutinib获FDA批准用于成人症状性皮肤划痕症，适应症由CSU拓展至慢性诱导性荨麻疹